Financial Statements

CytRx Corporation (CYTR)

$ 3.15
0.31 (+10.92%)
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in millions

Retained Earning Schedule

Year 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Retained Earnings (Previous Year) -464-457-451-416-365-307-276-229-211-
Net Income -7-7-13-35-51-59-30-47-18-14
Stock Dividends --7-------197
Dividend Paid ----------
Retained Earnings -471-464-457-451-416-365-307-276-229-211

PPE Schedule

Year 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Gross PPE 001211000-
Annual Depreciation 10-1-1212-000
Capital Expenditure -0-0-0-0-1-0-1-0-0-0
Net PPE 1001211000

Intangible and Goodwill Schedule

Year 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Intangible and Goodwill (Previous Year) -0000000--
New Purchases -23-29-27-57-66-----
Intangible and Goodwill 0000000---

CytRx Corporation income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes CytRx Corporation FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.